COSMO BIO COMPANY, LIMITED【JP:3386】Balance sheet

Market cap

¥7.9B

P/E ratio

33.8x

Cosmo Bio imports and sells life science research reagents and equipment to researchers at universities and corporations, offering over 10 million products from 500 companies worldwide.

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	981	1,098	1,648	1,383	2,068	2,416	3,159	3,255	3,036	2,826	2,393	2,747
Marketable securities, current	-	501	400	300	100	200	100	100	300	-	199	300	199
Accounts receivable, net	-	2,438	2,391	2,191	2,220	2,276	2,448	2,784	2,714	2,800	2,851	-	-
Inventories	-	1,082	1,115	1,184	1,225	969	820	572	805	1,055	959	989	1,011
Total current assets	-	5,234	5,266	5,495	5,143	5,668	5,927	6,756	7,310	7,136	7,102	7,229	7,441
Property, plant and equipment, net	-	213	227	319	690	636	695	636	599	577	572	701	862
Marketable securities, non-current	-	2,342	1,821	1,568	1,777	1,694	1,811	1,817	1,700	2,136	2,762	3,288	3,809
Total non-current assets	-	2,927	2,523	2,438	2,982	2,832	2,962	2,883	2,761	3,176	3,770	4,493	5,220
Total assets	-	8,161	7,790	7,934	8,126	8,501	8,890	9,640	10,072	10,313	10,872	11,723	12,662
Accounts payable	-	689	583	462	516	540	565	488	-	-	-	-	-
Short-term debt	-	20	20	20	20	20	20	20	20	20	20	20	20
Total current liabilities	-	1,130	1,017	916	799	945	987	1,226	1,093	1,038	1,123	1,166	1,422
Total non-current liabilities	-	497	394	436	488	502	581	552	658	656	722	1,001	1,284
Total liabilities	-	1,628	1,412	1,352	1,288	1,448	1,568	1,779	1,752	1,695	1,846	2,167	2,706
Retained earnings	-	3,397	3,521	3,680	3,812	4,026	4,181	4,761	5,274	5,560	5,805	5,891	5,880
Stockholders' equity	6,797	6,532	6,378	6,581	6,838	7,053	7,321	7,861	8,319	8,617	9,026	9,555	9,955
Working capital	-								-	-	-	-	-